Investors looking to back the next generation of weight-loss drugs, following a warning that the current blockbuster ...

Shares of WeightWatchers parent company WW International ($WW) have rocketed 40% higher on news that the company plans to ...

Investors in weight-loss drug companies like Novo Nordisk and Eli Lilly face concerns over side effects and market ...

Viking Therapeutics Inc. on Wednesday reported positive data from an early-stage trial of a treatment for the rare, and often fatal, metabolic disorder X-linked adrenoleukodystrophy, or X-ALD.

Novo Nordisk AS (NVO) reports a 25% sales increase, upgrades its full-year outlook, and addresses challenges in the insulin ...

A CNBC investigation into counterfeit weight-loss drugs revealed an international illegal marketplace where criminals either alter the drugs or ship the real product from overseas.

When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

Compounding pharmacies sued the FDA after its declaration, bringing an end to the sale of the "copycat" drugs they provide. Meanwhile, as demand soars for weight loss drugs, WeightWatchers eyes ...

In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as ...

Novo Nordisk’s stock declined 12% in the past month. Wegovy's sales growth stays under pressure. Read why I'm neutral on NVO ...

If you're like the vast majority of individual investors, you've never heard of Scholar Rock, apitegromab, or the muscle-wasting disease it could treat. Here's a quick look at the results that excited ...